Discovery and bioevaluation of cinnamic acid hydrazide as a sialic acid-dependent EV-D68 attachment inhibitor
Bioorganic Chemistry · 2026-11 · 184 · 110697
DOI: 10.1016/j.bioorg.2026.110697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Bidyadhar Sethy und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan. Hauptthemen laut MEDLINE: Cinnamates, Antiviral Agents, Drug Discovery, N-Acetylneuraminic Acid. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Science and Technology Council, Linkou Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Enterovirus D68 (EV-D68) poses a significant public health threat, causing respiratory illness and acute flaccid myelitis, yet no approved antiviral therapies exist. This study identified potent EV-D68 inhibitors through systematic screening of cinnamide analogs using a cell-based assay. The lead compound, CIN-01, exhibited promising antiviral activity (EC50 = 2.31 μM, SI > 43). Further structural optimization yielded CIN-12, demonstrating exceptional potency (EC50 = 0.087 μM) with remarkable selectivity (SI > 1149). CIN-12, a cinnamic acid hydrazide derivative, displayed broad-spectrum efficacy against multiple EV-D68 strains and Coxsackievirus genotypes, while maintaining minimal cytotoxicity. Time-of-addition studies revealed that CIN-12 primarily targets the early viral replication stage. Further, CIN-12 suppresses EV-D68 infection through a non-virucidal entry inhibition mechanism by selectively targeting the viral attachment phase, disrupting virus-host cell interaction in a sialic acid-dependent manner, with α2,6-linked sialic acid identified as the predominant determinant of this inhibitory effect. These findings position CIN-12 as a promising therapeutic agent that interferes with the entry/attachment phase of EV-D68 replication, offering a novel cinnamide-based approach to combat this emerging viral pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
- Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.
- Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College o…
- Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
- Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Förderung
- National Science and Technology Council
- Linkou Chang Gung Memorial Hospital
Zitieren
APA
Sethy, B., Nguyen, M. T., Narwanti, I., Hsieh, C. F., Chen, C. L., Cai, J. Y., Hsieh, P. W., Liou, J. P., & Horng, J. T. (2026). Discovery and bioevaluation of cinnamic acid hydrazide as a sialic acid-dependent EV-D68 attachment inhibitor. Bioorganic Chemistry, 184, 110697. https://doi.org/10.1016/j.bioorg.2026.110697
Vancouver
Sethy B, Nguyen MT, Narwanti I, Hsieh CF, Chen CL, Cai JY, et al. Discovery and bioevaluation of cinnamic acid hydrazide as a sialic acid-dependent EV-D68 attachment inhibitor. Bioorganic Chemistry. 2026;184:110697. doi:10.1016/j.bioorg.2026.110697
BibTeX
@article{Sethy2026,
author = {Sethy, Bidyadhar and Nguyen, Minh Thy and Narwanti, Iin and Hsieh, Chung-Fan and Chen, Chyi-Liang and Cai, Jie-Yun and Hsieh, Pei-Wen and Liou, Jing-Ping and Horng, Jim-Tong},
title = {Discovery and bioevaluation of cinnamic acid hydrazide as a sialic acid-dependent EV-D68 attachment inhibitor},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {184},
pages = {110697},
doi = {10.1016/j.bioorg.2026.110697}
}
EUVIMED